An "attenuator domain" is sandwiched by two distinct transactivation domains in the transcription factor C/EBP.
about
CCAAT/enhancer-binding proteins: structure, function and regulationUpstream open reading frames: molecular switches in (patho)physiologyCCAAT/enhancer binding protein alpha uses distinct domains to prolong pituitary cells in the growth 1 and DNA synthesis phases of the cell cycleA synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylationA novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOPCCAAT/enhancer-binding protein beta plays a regulatory role in differentiation and apoptosis of neuroblastoma cellsIncreased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alphaConformation of CCAAT/enhancer-binding protein alpha dimers varies with intranuclear location in living cells.c/CEPB, a chicken transcription factor of the leucine-zipper C/EBP family [corrected]The C/EBP family of transcription factors in the liver and other organs.Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation.Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinaseAXL mediates resistance to cetuximab therapySystematic analyses of rpm-1 suppressors reveal roles for ESS-2 in mRNA splicing in Caenorhabditis elegans.A multimerizing transcription factor of sea urchin embryos capable of looping DNA.Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3.Physical dissection of the CCAAT/enhancer-binding protein alpha in regulating the mouse amelogenin geneStearoyl-CoA desaturase 1 expression is downregulated in liver and udder during E. coli mastitis through enhanced expression of repressive C/EBP factors and reduced expression of the inducer SREBP1A.Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response.Hepatocyte nuclear factor 3 beta contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head proteinDefinition of the transcriptional activation domain of recombinant 43-kilodalton USF.Effects of age on the posttranscriptional regulation of CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated liversCCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection.CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity.CCAAT/enhancer-binding proteins alpha and beta interact with the silencer element in the promoter of glutathione S-transferase P gene during hepatocarcinogenesis.CCAAT/enhancer binding protein-alpha amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells.Impaired cyclic AMP-dependent phosphorylation renders CREB a repressor of C/EBP-induced transcription of the somatostatin gene in an insulinoma cell line.p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha.The alpha-isoform of the CCAAT/enhancer-binding protein is required for mediating cAMP responsiveness of the phosphoenolpyruvate carboxykinase promoter in hepatoma cells.A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergyC/EBPalphap30 plays transcriptional regulatory roles distinct from C/EBPalphap42.Identification of dominant-negative mutants of the herpes simplex virus type 1 immediate-early protein ICP0.Hepatocyte-like cells transdifferentiated from a pancreatic origin can support replication of hepatitis B virus.The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus.ADR1c mutations enhance the ability of ADR1 to activate transcription by a mechanism that is independent of effects on cyclic AMP-dependent protein kinase phosphorylation of Ser-230.NF-M (chicken C/EBP beta) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line.Identification of transcriptional activation and repression domains in human CCAAT/enhancer-binding protein epsilon.GATA factor-dependent regulation of cardiac m2 muscarinic acetylcholine gene transcription.Structural and functional studies of CCAAT/enhancer-binding protein epsilon.
P2860
Q24534323-431B74EF-7DA2-4D1F-B8F1-1FF8A8C54D13Q24614000-1BC60BCD-48E2-40BA-B4B2-68209003F08FQ24805510-B84F218E-4F84-47A5-B411-DEA3BCF18071Q28201630-D3A56DC1-E822-4969-9928-045E8E4B627DQ28216841-04EA2534-5858-4345-8431-6584648ACD7DQ28240554-7F8FBFFA-AB14-45DC-8C91-712940F21C33Q28512299-5A9B3AED-E4E1-44C7-BBC7-EE7C0800E984Q28591694-0904A3FB-9023-453F-A2F4-840533CAC80FQ30332416-01F297C5-00B5-4261-AA91-39CDDB9E1851Q33201650-C4D32B29-1048-4F97-8618-F12C11536135Q33630431-EE2B5C55-1AFC-484A-A1A0-48EA8F0AE94BQ33782419-3E2B934C-F38C-4326-9104-30DD24834B15Q33960787-55C6911E-AC3E-43CE-A66F-6336322B5A57Q34204829-7D38B3B8-790F-4EF4-AE3D-5DD75BF2172EQ34471570-8128CBB6-EB93-44D0-8A90-5333A1806957Q34524961-708B159D-8147-4615-91E8-7D968EDEA8D9Q34949789-4115DB99-D48C-440B-AEB0-7E7C0508A1ABQ35697170-6F0B7E31-B3AF-41CE-AF03-5B00D00D960AQ36083128-B3AF62A3-2FC3-46BC-BFC3-5387C78E4149Q36559345-E07824A5-4F1D-4043-85B7-7503624718B7Q36698768-052BE1FB-C5EE-4518-998B-3F55DA600E5BQ36705097-6648F0B4-015B-4F2A-9C60-E1C01624D096Q36878810-94478868-4BB3-4798-AB93-6C5AAE668D13Q37425262-E6EB3287-44D3-4EA8-B974-395F356F60D0Q37619789-906F456E-A4BC-4DDE-83D0-CE5D3F3A8CBCQ38287676-1476E7BF-ECCE-409D-BFD1-27C0F0089F03Q38292246-C61D0EA6-72F8-4FB2-A73A-E3534D3CCDFFQ38300455-680EF691-1184-43BA-A4E5-E5247AB6ECFBQ38301128-7E8D9605-C149-4A74-A474-AB9C1507221BQ38359300-56B2BA97-44DC-4471-8DC8-054760EEE29DQ39454884-986AE1A7-200D-4BAB-B6C9-39A5AD305557Q40180146-B13C7246-A855-4110-9C37-D2117FCC2E1AQ40308739-C5AB30CE-9976-4E3B-88F8-1FCA25F9275FQ40368002-4DF11CDB-F461-4762-B656-8A790439D0A0Q40500459-0D86AFDC-AD54-4F61-8BAA-C6CB3084F6EAQ40678436-5100403B-0808-4971-B47F-B7DE66857ED3Q40790195-86367249-C93B-4C92-B6C1-A43CE0F9B000Q41034641-B1A6BA8B-8A93-444F-9417-19E4958F3C54Q41043659-A2E9A43D-AFA6-4116-86D7-BDD44FBD0B7CQ43560069-A616D09C-3B2F-4C2C-8FF3-D5FE847728B4
P2860
An "attenuator domain" is sandwiched by two distinct transactivation domains in the transcription factor C/EBP.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
An "attenuator domain" is sand ...... he transcription factor C/EBP.
@en
type
label
An "attenuator domain" is sand ...... he transcription factor C/EBP.
@en
prefLabel
An "attenuator domain" is sand ...... he transcription factor C/EBP.
@en
P2860
P356
P1476
An "attenuator domain" is sand ...... he transcription factor C/EBP.
@en
P2093
P2860
P304
P356
10.1128/MCB.11.3.1480
P407
P577
1991-03-01T00:00:00Z